A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people, according to a new study. The vaccine, called Ad5-nCoV, is being developed by the Chinese company CanSino Biologics and was one of the first coronavirus vaccines to enter early human trials back in March.
No hay comentarios:
Publicar un comentario